comparemela.com

Latest Breaking News On - Revati shreeniwa - Page 1 : comparemela.com

Bright Minds Biosciences Appoints Drug Development

Dr. Smith is a 20-year pharmaceutical industry veteran with extensive central nervous system (“CNS”) clinical development expertise VANCOUVER,.

United kingdomUnited statesSan diegoBritish columbiaLisa wilsonMarka smithIan mcdonaldRevati shreeniwaYale universityUniversity of californiaCompany nasdaqShire pharmaceuticalsUs national institute of mental healthExperimental medicine of global clinical developmentPrincipal research scientistDiseases at dupont pharmaceuticals

Bright Minds Biosciences Appoints Drug Development Executive Mark A Smith M D , Ph D as Chief Medical Officer

Dr. Smith is a 20-year pharmaceutical industry veteran with extensive central nervous system clinical development expertise VANCOUVER, British Columbia, Nov. 23, 2022 Bright Minds. | November 23, 2022

United kingdomUnited statesSan diegoBritish columbiaLisa wilsonMarka smithIan mcdonaldRevati shreeniwaUniversity of californiaCompany nasdaqAstrazeneca pharmaceutical companyDupont pharmaceuticalsDuke university medical centerNeither the canadian securities exchangeRegulation services providerClinical development

vimarsana © 2020. All Rights Reserved.